Paragraph 11

In the Dangerous Substances and Preparations (Safety) (Consolidation) Regulations 1994 M1, in regulation 1 (citation, commencement and interpretation), in paragraph (2), in the definition of “medicinal product”—

(a)

for sub-paragraph (ii), substitute the following sub-paragraph—

“(ii)
which is an “investigational medicinal product” within the meaning of regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2003, or”; and

(b)

omit sub-paragraph (iii).

Annotations

Marginal citations

M1: S.I. 1994/2844; regulation 1(2) was substituted by S.I. 1996/2635.